IGHE and respiratory system disorder: After-treatment peanut skin prick test wheel size at 8 weeks and 12 months, peanut-specific and peanut component-specific IgE and IgG4 (Ara h 1, h 2, and h 3), as well as their changes from baseline. At 12 months after treatment completion, HRQOL was assessed via FAQLQ-PF, and the incidence of abdominal pain, vomiting, and systemic organ-related respiratory diseases (including preferred terms allergic cough, allergic respiratory tract, and respiratory adverse events) was significantly reduced.